Mesenchymal stem cell-derived exosomal CBLB ameliorates infantile pneumonia progression probably by ubiquitinating MAPK14
MSC-derived exosomal CBLB has therapeutic potential in ameliorating the progression of IP probably by ubiquitinating MAPK14, which could lead to novel clinical interventions for treating this condition.
Authors
- Zhenjiang Chen (ORCID: https://orcid.org/0000-0002-2833-5668)
- Na Niu (ORCID: https://orcid.org/0009-0006-0395-336X)
- Fang Guo (ORCID: https://orcid.org/0000-0002-9549-0457)
- Fuxing Song
- Lina Sun (ORCID: https://orcid.org/0000-0003-1268-7033)
- Min Yan (ORCID: https://orcid.org/0000-0002-7775-3153)
- Min Liu (ORCID: https://orcid.org/0000-0002-4698-6667)
Institutions
- Jinan City People's Hospital (CN)
- Shandong First Medical University (CN)
Publication Details
- Journal
- Journal of Inflammation
- Published
- 2025-06-19
- DOI
- https://doi.org/10.1186/s12950-025-00450-0
- Citations
- 1
- Primary Topic
- Extracellular vesicles in disease
- Type
- article
- Field-Weighted Citation Impact
- 0.81